The PROLONG Trial - Rituximab Maintenance Therapy in ITP

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This study is a two phase study that aims to evaluate if low-dose Rituximab maintenance therapy may prolong the the effect of Rituximab in immune thrombocytopenia.
Epistemonikos ID: 0db19d437c306ecc033e2385cbaca7ea6351acf6
First added on: May 20, 2024